Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,131 | 46 | 79.6% |
| Education | $290.45 | 3 | 20.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $255.54 | 7 | $0 (2022) |
| Chiesi USA, Inc. | $202.67 | 6 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $158.40 | 6 | $0 (2022) |
| Astellas Pharma US Inc | $154.99 | 2 | $0 (2020) |
| Amgen Inc. | $154.84 | 8 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $146.80 | 9 | $0 (2022) |
| Abbott Laboratories | $135.46 | 1 | $0 (2021) |
| GE HEALTHCARE | $66.68 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $22.23 | 1 | $0 (2022) |
| Medtronic Vascular, Inc. | $22.06 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $66.68 | 2 | GE HEALTHCARE ($66.68) |
| 2022 | $197.45 | 10 | Amgen Inc. ($38.98) |
| 2021 | $640.36 | 23 | Chiesi USA, Inc. ($161.62) |
| 2020 | $429.84 | 9 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($186.33) |
| 2019 | $87.13 | 5 | Medtronic Vascular, Inc. ($22.06) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $33.34 | General |
| 07/16/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $33.34 | General |
| 06/09/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/07/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/25/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/10/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.28 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Cardio-renal | ||||||
| 04/12/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Cardiology | ||||||
| 04/09/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $36.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Cardiology | ||||||
| 01/27/2022 | Chiesi USA, Inc. | KENGREAL (Drug), CLEVIPREX | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiology | ||||||
| 12/06/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Diabetes | ||||||
| 11/16/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Cardiology | ||||||
| 11/15/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/19/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/14/2021 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $5.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/13/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Cardiology | ||||||
| 09/23/2021 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $149.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/14/2021 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $5.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/25/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Cardiology | ||||||
| 08/23/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/12/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 972 | 1,037 | $124,975 | $42,657 |
| 2022 | 3 | 78 | 79 | $15,020 | $6,866 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 119 | $19,726 | $7,573 | 38.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 145 | 145 | $21,427 | $7,171 | 33.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 51 | 52 | $14,794 | $5,069 | 34.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 61 | 61 | $8,892 | $2,649 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $6,668 | $2,201 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 33 | 36 | $6,603 | $1,985 | 30.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 31 | $4,542 | $1,835 | 40.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 14 | $3,237 | $1,550 | 47.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 37 | $3,773 | $1,529 | 40.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 19 | 19 | $4,284 | $1,499 | 35.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,482 | $1,455 | 32.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $3,330 | $1,065 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 11 | $2,727 | $1,005 | 36.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 142 | 156 | $4,850 | $974.95 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $3,118 | $970.78 | 31.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 16 | 16 | $2,644 | $944.64 | 35.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 22 | 46 | $2,910 | $837.29 | 28.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 27 | 28 | $1,532 | $519.21 | 33.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 14 | 15 | $1,274 | $432.15 | 33.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 18 | 18 | $848.29 | $295.38 | 34.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 27 | 27 | $859.35 | $281.06 | 32.7% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 20 | 20 | $747.46 | $263.82 | 35.3% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 16 | 16 | $414.00 | $132.90 | 32.1% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 24 | 25 | $374.14 | $126.50 | 33.8% |
| 76376 | 3d radiographic procedure | Facility | 2023 | 17 | 17 | $371.00 | $117.60 | 31.7% |
About Dr. Mikhail Romashko, MD
Dr. Mikhail Romashko, MD is a Internal Medicine healthcare provider based in Biddeford, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2016. The National Provider Identifier (NPI) number assigned to this provider is 1427407931.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mikhail Romashko, MD has received a total of $1,421 in payments from pharmaceutical and medical device companies, with $66.68 received in 2024. These payments were reported across 49 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,131).
As a Medicare-enrolled provider, Romashko has provided services to 1,050 Medicare beneficiaries, totaling 1,116 services with total Medicare billing of $49,523. Data is available for 2 years (2022–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Biddeford, ME
- Active Since 06/06/2016
- Last Updated 04/22/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427407931
Products in Payments
- LifeVest (Device) $255.54
- KENGREAL (Drug) $175.51
- XARELTO (Drug) $158.40
- Repatha (Biological) $141.53
- EnSite Precision Cardiac Mapping System (Device) $135.46
- BRILINTA (Drug) $131.80
- INJECTAFER (Drug) $22.23
- Visia AF (Device) $22.06
- ELIQUIS (Drug) $21.79
- Kerendia (Drug) $17.46
- Vascepa (Drug) $17.37
- Ozempic (Drug) $16.59
- LOKELMA (Drug) $15.00
- NEXLETOL (Drug) $14.66
- KENGREAL 50MG/10ML L (Drug) $14.47
- ENTRESTO (Drug) $13.92
- Corlanor (Drug) $13.31
- CLEVIPREX (Drug) $12.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Biddeford
Dr. Peter Rubin, M.d, M.D
Internal Medicine — Payments: $31,481
Yasmin Mahal, Do, DO
Internal Medicine — Payments: $2,642
Steven Cutone, D.o, D.O
Internal Medicine — Payments: $2,606
Jennifer Cutone, M.d, M.D
Internal Medicine — Payments: $2,262
Dr. Mahesh Bandara, M.d, M.D
Internal Medicine — Payments: $1,733
Dr. Woodrow Lee, Do, DO
Internal Medicine — Payments: $1,712